HUP0202893A3 - Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them - Google Patents
Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing themInfo
- Publication number
- HUP0202893A3 HUP0202893A3 HU0202893A HUP0202893A HUP0202893A3 HU P0202893 A3 HUP0202893 A3 HU P0202893A3 HU 0202893 A HU0202893 A HU 0202893A HU P0202893 A HUP0202893 A HU P0202893A HU P0202893 A3 HUP0202893 A3 HU P0202893A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- dione derivatives
- substituted benzylthiazolidine
- benzylthiazolidine
- Prior art date
Links
- JIMXJAFZPUUCAD-UHFFFAOYSA-N 3-benzyl-1,3-thiazolidine-2,4-dione Chemical class O=C1CSC(=O)N1CC1=CC=CC=C1 JIMXJAFZPUUCAD-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23552899 | 1999-08-23 | ||
| PCT/JP2000/005520 WO2001014350A1 (en) | 1999-08-23 | 2000-08-18 | Substituted benzylthiazolidine-2,4-dione derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202893A2 HUP0202893A2 (hu) | 2002-12-28 |
| HUP0202893A3 true HUP0202893A3 (en) | 2004-12-28 |
Family
ID=16987319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202893A HUP0202893A3 (en) | 1999-08-23 | 2000-08-18 | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6545026B1 (hu) |
| EP (1) | EP1207156B1 (hu) |
| KR (1) | KR20020022811A (hu) |
| CN (1) | CN1152025C (hu) |
| AT (1) | ATE295841T1 (hu) |
| AU (1) | AU778723B2 (hu) |
| CA (1) | CA2382581C (hu) |
| DE (1) | DE60020246T2 (hu) |
| HU (1) | HUP0202893A3 (hu) |
| TW (1) | TWI225051B (hu) |
| WO (1) | WO2001014350A1 (hu) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1348698A4 (en) | 2000-12-05 | 2005-01-19 | Kyorin Seiyaku Kk | SUBSTITUTED CARBOXYLENE DERIVATIVES |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| IL156445A0 (en) | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| SI1355644T1 (sl) | 2001-01-26 | 2006-10-31 | Schering Corp | Uporaba substituiranih azetidinonskih spojin za zdravljenje sitosterolemije |
| EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
| DK1429756T3 (da) | 2001-09-21 | 2007-03-19 | Schering Corp | Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| WO2003050097A1 (en) * | 2001-12-11 | 2003-06-19 | Kyorin Pharmaceutical Co., Ltd. | Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof |
| WO2003062214A1 (en) * | 2002-01-23 | 2003-07-31 | Kyorin Pharmaceutical Co., Ltd. | Novel stable crystal of benzylthiazolidinedione derivative and method for preparation thereof |
| US20040092499A1 (en) | 2002-11-06 | 2004-05-13 | Schering Corporation | Methods and therapeutic combinations for the treatment of autoimmune disorders |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| ATE418551T1 (de) | 2003-03-07 | 2009-01-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| CN1756755A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| EP1896462A2 (en) * | 2005-05-31 | 2008-03-12 | The Pfahl Family Trust (Dated 9 July 1996) | Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| US20080241215A1 (en) * | 2007-03-28 | 2008-10-02 | Robert Falotico | Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3144624B2 (ja) * | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| JP3929512B2 (ja) * | 1995-06-02 | 2007-06-13 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| US6001862A (en) * | 1995-06-02 | 1999-12-14 | Kyorin Pharameuticals Co., Ltd. | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| WO1997032863A1 (en) * | 1996-03-08 | 1997-09-12 | Torii Pharmaceutical Co., Ltd. | Thiazolidine-2,4-dione derivatives |
| JPH09301963A (ja) * | 1996-05-17 | 1997-11-25 | Kyorin Pharmaceut Co Ltd | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
-
2000
- 2000-08-18 HU HU0202893A patent/HUP0202893A3/hu unknown
- 2000-08-18 US US10/049,905 patent/US6545026B1/en not_active Expired - Fee Related
- 2000-08-18 DE DE60020246T patent/DE60020246T2/de not_active Expired - Fee Related
- 2000-08-18 CA CA002382581A patent/CA2382581C/en not_active Expired - Fee Related
- 2000-08-18 WO PCT/JP2000/005520 patent/WO2001014350A1/ja not_active Ceased
- 2000-08-18 EP EP00953476A patent/EP1207156B1/en not_active Expired - Lifetime
- 2000-08-18 AU AU65946/00A patent/AU778723B2/en not_active Ceased
- 2000-08-18 CN CNB008147108A patent/CN1152025C/zh not_active Expired - Fee Related
- 2000-08-18 AT AT00953476T patent/ATE295841T1/de not_active IP Right Cessation
- 2000-08-18 KR KR1020027001993A patent/KR20020022811A/ko not_active Ceased
- 2000-08-22 TW TW089116994A patent/TWI225051B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2382581C (en) | 2007-06-12 |
| US6545026B1 (en) | 2003-04-08 |
| DE60020246D1 (de) | 2005-06-23 |
| AU778723B2 (en) | 2004-12-16 |
| CN1382131A (zh) | 2002-11-27 |
| EP1207156A4 (en) | 2002-09-18 |
| TWI225051B (en) | 2004-12-11 |
| KR20020022811A (ko) | 2002-03-27 |
| CN1152025C (zh) | 2004-06-02 |
| DE60020246T2 (de) | 2006-01-19 |
| ATE295841T1 (de) | 2005-06-15 |
| WO2001014350A1 (en) | 2001-03-01 |
| CA2382581A1 (en) | 2001-03-01 |
| HUP0202893A2 (hu) | 2002-12-28 |
| EP1207156A1 (en) | 2002-05-22 |
| EP1207156B1 (en) | 2005-05-18 |
| AU6594600A (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202520A3 (en) | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them | |
| HUP0203403A3 (en) | New imidazole derivatives, pharmaceutical compositions containing them and their use | |
| IL149473A0 (en) | Heterocyclic dihydropyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL144501A0 (en) | Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0105003A3 (en) | 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them | |
| HUP0200155A3 (en) | Thioamide derivatives, pharmaceutical compositions containing them and their use | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150346A (en) | Benzazole derivatives, their preparation and pharmaceutical compositions containing them | |
| ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
| IL149757A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing the same | |
| IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| HUP0400540A3 (en) | 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them | |
| IL145428A0 (en) | Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| IL152094A0 (en) | Ecteinascidin derivatives and pharmaceutical compositions containing the same | |
| HUP0202893A3 (en) | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them | |
| HUP0202701A3 (en) | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| IL157740A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| HUP0201714A3 (en) | Substituted heterocyclic compounds and pharmaceutical compositions containing them | |
| HUP0204154A3 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |